Business Standard

ICICI Venture to sell Vetnex stake to Pfizer for Rs 200 cr

Related News

today announced signing of a definitive share purchase agreement to sell all common shares of RFCL’s Vetnex Animal Health to of world’s largest drug maker Pfizer. The acquisition is expected to close by August 2009, subject to necessary regulatory approvals.

Vetnex Animal Health is a part of RFCL, a significant stake in which was acquired by ICICI Venture from Ranbaxy Laboratories for Rs 125 crore in 2005.

Though ICICI Venture did not disclose much, sources said the deal was worth over Rs 200 crore and that Vetnex had an annual turnover of Rs 100-120 crore. French animal healthcare majors Virbac and Sanofi-Aventis were also in the race, they said. When contacted, RFCL executives declined to comment.

Vetnex is a market leader in poultry, livestock and pet healthcare and is one of the top three players in the Indian animal healthcare market. The company is valued at about Rs 1,400 crore.

RFCL, which operates in chemicals, diagnostics and animal healthcare sectors, had de-merged its animal health division into Vetnex earlier this year.

Read more on:   
|

Read More

Sensex ends at 3-week low; sentiment still weak

The Sensex fell to a three-week low on Monday after disappointing quarterly earnings hit Bank of Baroda and IDFC, while investors continued to book ...

Quick Links

 

Market News

Markets come off day highs; Infy, Wipro down 1%

Sensex has gained 320 points at 26,428 while Nifty has climbed 95 points to trade at 7,875

Unichem Lab dips on disappointing Q2 results

The stock slipped 8% to Rs 204 after reporting 38% yoy declined in net profit at Rs 22 crore in September quarter.

Oil prices extend gains in Asia

Prices were lifted by a surge in equities following last week's sharp gains on Wall Street

Reliance Industries hits six-month low

The stock dipped nearly 3% to Rs 913, its lowest level since March 31 this year on Bombay Stock Exchange.

UltraTech Cement gains as Q2 earnings beat estimates

Consolidated net profit rose for Jul-Sep increased 47% to Rs 416 crore against Rs 283 crore in the same quarter last fiscal

Back to Top